Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine

Infection and Immunity

Volumn 68, Issue 11, 2000, Pages 6202-6208

  Bennett Guerrero, E ^a   McIntosh, T J ^a   Barclay, G R ^a   Snyder, D S ^a   Gibbs, R J ^a   Mythen, M G ^a   Poxton, I R ^a  

^a Columbia Univ Coll of Phys/Surg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CHOLESTEROL; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLGLYCEROL; ENDOTOXIN; LIPOSOME; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BACTEROIDES; BACTEROIDES FRAGILIS; CONTROLLED STUDY; CROSS REACTION; ESCHERICHIA COLI; HIGH RISK PATIENT; IMMUNOBLOTTING; KLEBSIELLA PNEUMONIAE; LIMULUS LYSATE TEST; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; SEROTYPE; STRAIN DIFFERENCE; TOXICITY; VACCINATION;

ANIMAL; BACTERIAL VACCINES; FEMALE; IMMUNIZATION; LIPOPOLYSACCHARIDES; LIPOSOMES; MALE; MICE; MICE, INBRED C57BL; RABBITS; SUPPORT, NON-U.S. GOV'T;

EID: 0033784262     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.11.6202-6208.2000     Document Type: Article

References (40)

1. Immunological control of Pseudomonas infection in burn patients: A clinical evaluation
2. Anti-Bacteroides lipopolysaccharide IgG levels in healthy adults and sepsis patients
3. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants
4. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5
5. Systemic inflammation
6. Relationship of preoperative serum anti-endotoxin-core antibody levels and adverse outcomes following cardiac surgery
7. Exposure to Bacteroides fragilis endotoxoin during cardiac surgery
8. AmBisome (liposomal amphotericin B): A comparative review
9. Treatment of gram-negative septic shock with human IgG antibody to Eschedchia coli J5: A prospective, double-blind, randomized trial
10. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma
11. Frequency of Escherichia coli serotypes in urinary infections
12. Synthesis and characterization of a polyvalent Escherichia coli O-polysaccharide-toxin A conjugate vaccine
13. A re-appraisal of the biological activity of Bacteroides lipopolysaccharide
14. Tumor necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species
15. Immunization with rough mutants of Salmonella minnesota: Initial studies in human subjects
16. A procedure for the efficient incorporation of wild-type lipopolysaccharide into liposomes for use in immunological studies
17. Typhoid fever vaccines: A meta-analysis of studies on efficacy and toxicity
18. Prevention of fever and gram negative infection after open heart surgery by antiendotoxin
19. Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy
20. Frequencies of lipopolysaccharide core types among clinical isolates of Escherichia coli defined with monoclonal antibodies
21. Prevention of clinical coliform mastiffs in dairy cows by a mutant Escherichia coli vaccine
22. Antibody to endotoxin is associated with decreased frequency of postoperative infection
23. Bacteremia due to Escherichia coli: A study of 861 episodes
24. Relationship between preoperative endotoxin immune status, gut perfusion, and outcome from cardiac valve replacement surgery
25. Controlled trial of Pseudomonas immunoglobulin and vaccine in burn patients
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Cross-reactive antigens: Their potential for immunization-induced immunity to gram-negative bacteria
28. Ineffectiveness of single-dose human antiserum to core glycolipid (E. coli J5) for prophylaxis of bacteremic, gram-negative infections in patients with prolonged neutropenia
29. A comparison of immunoblotring, flow cytometry and ELISA to monitor the binding of anti-lipopolysaccharide monoclonal antibodies
30. A comparative study of nosocomial and community-acquired strains of Escherichia coli causing bacteraemia in a Danish University hospital
31. Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes
32. Antibodies to lipopolysaccharide
33. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
34. Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: Superior antibody content of an IgM-enriched product
35. O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections
36. A simple method for isolation of lipopolysaccharides from Pseudornonas aeruginosa and some other bacterial strains
37. Characteristics of Pseudornonas aeruginosa strains causing septicemia in a Spanish hospital 1981-1990
38. Pseudomonas aeruginosa vaccine in cancer patients
39. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coil N